La Jolla, CANCT07509151Now EnrollingIRB Ready

Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV Clinical Trial in La Jolla, CA

Access cutting-edge chronic lymphocytic leukaemia or small lymphocytic lymphoma with unmutated ighv treatment through this phase 3 clinical trial at a research site in La Jolla. Study-provided care at no cost to qualified participants.

Sponsored by AstraZeneca

Quick Self-Assessment

See if you qualify for this La Jolla location

Preparing your pre-screening questions…

Expert Care in La Jolla

Access chronic lymphocytic leukaemia or small lymphocytic lymphoma with unmutated ighv specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic lymphocytic leukaemia or small lymphocytic lymphoma with unmutated ighv treatment provided free

Apply for This La Jolla Location

Check if you qualify for this chronic lymphocytic leukaemia or small lymphocytic lymphoma with unmutated ighv clinical trial in La Jolla, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to La Jolla

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit La Jolla site if eligible
  4. 4Begin participation

About This Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV Study in La Jolla

The purpose of this study is to evaluate the therapeutic benefit and safety of subcutaneous (SC) Surovatamig monotherapy as consolidation therapy in patients with Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) with unmutated IGHV (uIGHV).

Sponsor: AstraZeneca

Who Can Participate

Inclusion Criteria

Documented diagnosis of CLL/SLL with genomic features defined by unmutated IGHV.
Treatment received and response at the end of 1L (first-line) finite therapy.
Participants with SLL (except those in CR in Phase III part) must have measurable disease (nodal or extranodal) with at least one measurable target lesion.
ECOG performance status of 0 to 2.
Adequate haematologic, liver, renal and cardiac function.
Female participants: must be either women not of childbearing potential or must use a highly effective form of contraception.
Male participants who intend to be sexually active with females of childbearing potential must agree to use barrier contraception (eg, condoms).

Exclusion Criteria

Suspected or confirmed transformation of CLL/SLL to a more aggressive form of lymphoma (ie, Richter's transformation, prolymphocytic leukaemia, or DLBCL).
Evidence of active or history of Central Nervous System (CNS) involvement by CLL/SLL.
History of or ongoing confirmed progressive multifocal leukoencephalopathy.
Participants who have any concurrent or history of malignancy.
Participants with:
Active or uncontrolled infection (including Epstein-Barr virus-EBV) requiring systemic therapy.
Participants with known history of Heamophagocytic lymphohistiocytosis (HLH).
Human Immunodeficiency Virus (HIV) infection, or participants with chronic or active infection with Hepatitis B Virus (HBV) or Hepatitis C Virus (HCV).
Major cardiac abnormalities.
Prior CLL/SLL-specific therapies.
Requires chronic immunosuppressive therapy for active autoimmune/inflammatory condition or prior allogeneic stem cell or solid organ transplant.
Major surgical procedure.
Known hypersensitivity to surovatamig or any of the excipients of the product.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in La Jolla?

Yes, this clinical trial (NCT07509151) has an active research site in La Jolla, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV Treatment Options in La Jolla, CA

If you're searching for chronic lymphocytic leukaemia or small lymphocytic lymphoma with unmutated ighv treatment options in La Jolla, CA, this clinical trial (NCT07509151) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our La Jolla research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced chronic lymphocytic leukaemia or small lymphocytic lymphoma with unmutated ighv specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic lymphocytic leukaemia or small lymphocytic lymphoma with unmutated ighv clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in La Jolla, CA

See all leukemia clinical trials recruiting in La Jolla — not just this study.

Browse Leukemia Trials in La Jolla →

Browse More Trials by Condition

Leukemia TrialsLymphoma TrialsChronic Lymphocytic Leukemia TrialsHeart Attack TrialsPulmonary Hypertension TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsSpinal Muscular Atrophy TrialsAll Conditions →

Ready to Join in La Jolla?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · La Jolla, CA